Clinical Trials Logo

Gonarthrosis clinical trials

View clinical trials related to Gonarthrosis.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06302075 Recruiting - Gonarthrosis Clinical Trials

Functional Recovery After Medial Monocompartmental Knee Prosthesis: One Day Protocol Versus Fast Protocol

UKA-L2086
Start date: November 16, 2021
Phase: N/A
Study type: Interventional

The study is defined as prospective, randomized, interventional single-center; the general aim is to evaluate the post-operative recovery of the patient who carries out rehabilitation with the one day protocol (Group A), compared to the patient who carries out rehabilitation during the hospital stay with the fast protocol (group B).

NCT ID: NCT06087705 Recruiting - Gonarthrosis Clinical Trials

Real-life Assessment of the Safety and Performance of the SYNOVIUM HCS Device

YNOVIUM
Start date: February 7, 2023
Phase:
Study type: Observational

Patients who are to benefit from an injection of SYNOVIUM HCS as part of their care will be offered to participate in this study. Patients will need to sign a consent form to participate. Prior to SYNOVIUM HCS injection, patients will be asked a series of questions regarding their pain and disability. Data collected during follow-up visits can be compared to pre-injection data.

NCT ID: NCT06003413 Recruiting - Osteoarthritis Clinical Trials

Evaluation of the Relationship Between Muscle Architecture and Muscle Strength in Female Gonarthrosis Patients

Start date: August 24, 2023
Phase:
Study type: Observational

The goal of this cross-sectional study is to evaluate muscle architecture changes and it's effect on muscle strength in female patients with gonarthrosis.Main questions are: - Is there any correlation between muscle strength and muscle thickness, pennation angle fiber length? - Is there any muscle architecture difference in gonarthrosis and is it effecting the muscle strength? The investigators will enroll patients with unilateral gonarthrosis so that investigators can compare the changes within osteoarthritic and healthy knee with the same physical activity levels.

NCT ID: NCT05814471 Recruiting - Gonarthrosis Clinical Trials

Validation orthèse Pour Gonarthrose

Start date: March 30, 2023
Phase: N/A
Study type: Interventional

A study about the effects of different fastening systems for knee braces on comfort, ease of installation and treatment efficacy both physical and psychological. Two different systems will be tested, velcro straps and a cable-fastening system.

NCT ID: NCT05487053 Recruiting - Clinical trials for Osteo Arthritis Knee

The Impact of Single-shot Adductor Canal Block Versus Continuous Femoral Nerve Block on Rehabilitation After Total Knee Replacement

Start date: February 3, 2024
Phase: N/A
Study type: Interventional

Total knee replacement (TKR) is considered the most effective and safe method of radical treatment of late stages of knee osteoarthritis. A well-known problem of TKR is a severe postoperative pain syndrome, which is observed in more than 50% of patients. Femoral nerve block (FNB) is the "gold standard" for continuous postoperative analgesia after total knee replacement, as it is effective in reducing the frequency of use of opioid analgetics and reduce the duration of hospitalization. At the same time, the negative effect of this method is the motor blockade of the quadriceps femoris muscle which leads to functional impairment and is associated with an increased risk of falling. Adductor canal block (ACB) provides adequate analgesia comparable to femoral nerve block. Moreover, ACB doesn't affect the motor function of the quadriceps femoris muscle. The possibility of enhanced recovery after total knee replacement is the reason to compare single-shot adductor canal block and continuous femoral nerve block.

NCT ID: NCT05062109 Recruiting - Osteoarthritis Clinical Trials

Multimodal Geriatric Pre-authorization Before Scheduled Orthopedic Surgery

PRE4OS
Start date: June 16, 2021
Phase: N/A
Study type: Interventional

The main objective of this multicentric, prospective and interventional study is to assess the feasibility of multimodal prehabilitation in patients aged 75 years or older with surgical indication for coxarthrosis or severe gonarthrosis

NCT ID: NCT04424628 Recruiting - Gonarthrosis Clinical Trials

Radiotherapy 3 vs 6 Gy in Gonarthrosis and Coxarthrosis

RAGOCO
Start date: May 1, 2019
Phase: N/A
Study type: Interventional

This is a non-inferiority study in which the investigators compare two low-dose radiotherapy schemes, which are recommended from DEGRO Clinical Practice Guidelines (3 Gy vs 6 Gy) for the treatment of osteoarthritis and other osteodegenerative disorders. A first randomization will be carried out among the patients included in the study: - Patients in arm A will be treated at 3 Gy (0.5 Gy/fraction, 3 fractions/week), and patients in arm B will be treated at 6 Gy (1 Gy/fraction, 3 fractions/week). - Patients should not know the arm to which they have been randomized. - Once the treatment is finished, patients will be assessed at 8 weeks. If pain does not improve, a re-irradiation will be performed. If the patients were treated with 3 Gy a new randomization will be performed (3 vs 6 Gy again). If the patiens were treated with 6 Gy they will be re-irradiated with 6 Gy again. The investigators will analyze the results obtained depending on the dose received and depending on the location of the treatment.

NCT ID: NCT04318197 Recruiting - Arthroplasty Clinical Trials

Rehabilitation With Personalized Strategies According to Muscle Volume Before Knee Arthroplasty

REPERAGE
Start date: December 18, 2020
Phase: N/A
Study type: Interventional

Preoperative rehabilitation before total knee arthroplasty (TKA) has not been proven to be effective. Latest meta-analyzes do not find any improvement of motor performance during gait 6 months after surgery. However, most of the previous studies did not specifically target muscle atrophy to design rehabilitation protocol. Pre-operative muscle atrophy, although not systematic, is often observed. The preoperative muscles volumes of thigh muscles have been poorly identified and never used to adjust the pre operative rehabilitation strategy. As part of the "FOLLOWKNEE" (RHU) project, which attempts to implement a personalized management of TKA and its follow-up, this study wants to explore the potential effect of adapted treatment to improve muscle force and muscle volume before TKA.

NCT ID: NCT04313894 Recruiting - Gonarthrosis Clinical Trials

WHARTON JELLY ORIGINATED MESENCHIAL STEM CELL in GONARTHROSIS

WHAMKO
Start date: January 1, 2019
Phase: Phase 2
Study type: Interventional

Osteoarthritis (OA) is a progressive disease characterized by degeneration of the joint cartilage, which is involved in the immune system leading to proinflammatory cytokine and metalloproteinase release. Knee osteoarthritis is the most common form. The healing is very slow and the damage is not fully recovered, so the degeneration process continues and no treatment modalities completely remove this process. Various methods are used in the treatment of OA and total joint replacement is performed in the patients with OA recently. Ten patients with Kellgren-Lawrence grade II-III knee OA who had been applied for knee pain and received conservative treatment for 6 months and had no benefit will be taken to study. Patients will be assessed 7 (V1-7) times during the study. Clinical, immunologic and radiological treatment effectiveness and clinical improvement will be evaluated at the beginning of the treatment and in all follow-up patients participating in the study.

NCT ID: NCT04019782 Recruiting - Knee Osteoarthritis Clinical Trials

Collagen-PVP vs Hylan G-F 20 in the Treatment of Knee Osteoarthritis

Start date: August 1, 2019
Phase: Phase 3
Study type: Interventional

Articular cartilage degradation is the main characteristic of osteoarthritis (OA), involving enzymatic and inflammatory mechanisms that change it into a chronic disease. Since articular cartilage shows limited regenerative ability, several intra-articular drugs have been developed in order to decrease inflammation and provide a better clinical outcome to the patient.